Abstract
Aminopeptidase N/CD13 is a Zn2+-dependent exoprotease present on the cell surface as a transmembrane protein. Our previous studies using aminopeptidase inhibitors and antibodies demonstrated that aminopeptidase N is involved in the degradation and invasion of the extracellular matrix (ECM) by metastatic tumor cells. In the present study we transfected human A375M melanoma cells with eukaryotic plasmid expression vectors that contained full length cDNA of aminopeptidase N/CD13 and examined their characteristics. The transfectants that expressed extremely high levels of aminopeptidase N/CD13 degraded type IV collagen and invaded ECM more actively than the parental and control vector-transfected cells. Furthermore, the aminopeptidase N/CD13-transfected A375M cells had significantly augmented lung colonizing potential in nude mice. The results show that the aminopeptidase N/CD13 plays an active role in degradation and invasion of ECM and may be involved in the molecular mechanisms of blood-borne metastasis.
Keywords: aminopeptidase N, CD13, invasion, melanoma, metastasis
References
- 1.Fidler IJ, Fabra A, Nakajima M, Radinsky R. Genetic and epigenetic regulation of human colon carcinoma metastasis. Contrib Oncol. 1992;44:13–26. [Google Scholar]
- 2.Nicolson GL. Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev. 1993;12:325–43. doi: 10.1007/BF00665961. [DOI] [PubMed] [Google Scholar]
- 3.Liotta LA, Tryggvason K, Garbisa S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980;284:67–8. doi: 10.1038/284067a0. [DOI] [PubMed] [Google Scholar]
- 4.Liotta LA, Goldfarb RH, Brundage R. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 1989;41:4629–36. [PubMed] [Google Scholar]
- 5.Sloane BF, Horn KV, Sadler JG. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res. 1982;42:980–6. [PubMed] [Google Scholar]
- 6.Saiki I, Murata J, Watanabe K. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro. Japan J Cancer Res. 1989;80:873–8. doi: 10.1111/j.1349-7006.1989.tb01729.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Look AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase. N. J Clin Invest. 1989;83:1299–307. doi: 10.1172/JCI114015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Delmas B, Gelfi J, L'Haridon R. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature. 1992;357:417–20. doi: 10.1038/357417a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Yeager CL, Ashmun RA, Williams RK. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature. 1992;357:420–2. doi: 10.1038/357420a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Amoscato AA, Sramkoski RM, Babcock GF, Alexander JW. Neutral surface aminopeptidase activity of human tumor cell lines. Biochim Biophys Acta. 1990;1041:317–9. doi: 10.1016/0167-4838(90)90291-m. [DOI] [PubMed] [Google Scholar]
- 11.Chop AM, Nakajima M, Nicolson GL. Metastatic mammary adenocarcinoma cell lines express elevated levels of plasma membrane cathepsin H-like and aminopeptidase-like activities. Proc Am Assoc Cancer Res. 1989;30:98. [Google Scholar]
- 12.Yoneda J, Saiki I, Fujii H. Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin) Clin Exp Metastasis. 1992;10:49–59. doi: 10.1007/BF00163576. [DOI] [PubMed] [Google Scholar]
- 13.Saiki I, Fujii H, Yoneda J. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer. 1993;54:137–43. doi: 10.1002/ijc.2910540122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Nakajima M, Welch DR, Belloni PN, Nicolson GL. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res. 1987;47:4869–76. [PubMed] [Google Scholar]
- 15.Saiki I, Iida J, Murata J. Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules. Cancer Res. 1989;49:3815–22. [PubMed] [Google Scholar]
- 16.Nakajima M, Lotan D, Baig MM. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res. 1989;49:1698–706. [PubMed] [Google Scholar]
- 17.Tsuruo T, Naganuma K, Iida H. Inhibition of lymph node metastasis of P388 leukemia by bestatin in mice. J Antibiot. 1981;34:1206–9. doi: 10.7164/antibiotics.34.1206. [DOI] [PubMed] [Google Scholar]
- 18.Talmadge JE, Lenz BF, Pennington R. Immunomodulatory and therapeutic properties of bestatin in mice. Cancer Res. 1986;46:4505–10. [PubMed] [Google Scholar]
- 19.Menrad A, Speicher D, Wacker J, Herlyn M. Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res. 1993;53:1450–5. [PubMed] [Google Scholar]
- 20.Morahan PS, Edelson PJ, Gass K. Changes in macrophage ectoenzymes associated with anti-tumor activity. J Immunol. 1980;125:1312–7. [PubMed] [Google Scholar]
- 21.Liotta LA, Abe S, Robey PG, Martin GR. Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc Natl Acad Sci USA. 1979;76:2268–72. doi: 10.1073/pnas.76.5.2268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Nakajima M, Chop AM. Tumor invasion and extracellular matrix degrading enzymes: regulation of activity by organ factors. Sem Cancer Biol. 1991;2:115–27. [PubMed] [Google Scholar]